LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Aurinia Pharmaceuticals Inc

Fechado

SetorSaúde

8.18 1.36

Visão Geral

Variação de preço das ações

24h

Atual

Mín

8.08

Máximo

8.33

Indicadores-chave

By Trading Economics

Rendimento

22M

23M

Vendas

2.6M

62M

P/E

Médio do Setor

29.482

51.198

EPS

0.16

Margem de lucro

37.371

Funcionários

130

EBITDA

15M

22M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+20.52% upside

Dividendos

By Dow Jones

Próximos Ganhos

31 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-53M

1.1B

Abertura anterior

6.82

Fecho anterior

8.18

Sentimento de Notícias

By Acuity

50%

50%

167 / 380 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Aurinia Pharmaceuticals Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de jun. de 2025, 20:45 UTC

Ganhos

Broadcom 2Q Sales Climb on Booming AI Demand

5 de jun. de 2025, 23:45 UTC

Conversa de Mercado

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 de jun. de 2025, 23:44 UTC

Conversa de Mercado

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 de jun. de 2025, 23:30 UTC

Conversa de Mercado

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 de jun. de 2025, 21:32 UTC

Ganhos

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 de jun. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

5 de jun. de 2025, 20:45 UTC

Ganhos

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 de jun. de 2025, 20:24 UTC

Ganhos

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q Rev $15B >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q Net $4.97B >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q Adj EPS $1.58 >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom 2Q EPS $1.03 >AVGO

5 de jun. de 2025, 20:15 UTC

Ganhos

Broadcom Sees 3Q Rev $15.8B >AVGO

5 de jun. de 2025, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 de jun. de 2025, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 de jun. de 2025, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 de jun. de 2025, 19:22 UTC

Conversa de Mercado

Oil Futures Resume Upward Moves -- Market Talk

5 de jun. de 2025, 19:00 UTC

Conversa de Mercado

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 de jun. de 2025, 18:32 UTC

Conversa de Mercado

Gold Slips After Trump-Xi Call -- Market Talk

5 de jun. de 2025, 18:26 UTC

Ganhos

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 de jun. de 2025, 18:06 UTC

Conversa de Mercado

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 de jun. de 2025, 16:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 de jun. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

5 de jun. de 2025, 16:18 UTC

Conversa de Mercado

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 de jun. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

5 de jun. de 2025, 16:12 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

5 de jun. de 2025, 16:12 UTC

Conversa de Mercado

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 de jun. de 2025, 16:03 UTC

Conversa de Mercado

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 de jun. de 2025, 15:49 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparação entre Pares

Variação de preço

Aurinia Pharmaceuticals Inc Previsão

Preço-alvo

By TipRanks

20.52% parte superior

Previsão para 12 meses

Média 9.75 USD  20.52%

Máximo 11 USD

Mínimo 8 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Aurinia Pharmaceuticals Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

4

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

8.1 / 8.21Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

167 / 380 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.